Literature DB >> 446911

Blood glucose regulates the effects of insulin and counterregulatory hormones on glucose production in vivo.

L Saccà, P E Cryer, R S Sherwin.   

Abstract

Continuous, low dose, insulin infusion in conscious dogs produced moderate hypoglycemia but only a transient fall in glucose production that rose towards preinfusion levels 20 to 30 min before any detectable increase in plasma counterregulatory hormones. Addition of epinephrine or glucagon to the insulin infusion prevented the fall in glucose production throughout the experiment but only partially diminished the hypoglycemic response. When hypoglycemia was prevented by a variable glucose infusion, neither epinephrine nor glucagon was able to counteract the suppressive effect of insulin on glucose output. These findings suggest that a fall in blood glucose per se may reverse insulin-induced inhibition of glucose production independent of a rise in counterregulatory hormones and that the insulin antagonist effect of counter-regulatory hormones is modulated, at least in part, by blood glucose concentration.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 446911     DOI: 10.2337/diab.28.6.533

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  11 in total

1.  Insulin-induced hypoglycemia increases hepatic sensitivity to glucagon in dogs.

Authors:  Noelia Rivera; Christopher J Ramnanan; Zhibo An; Tiffany Farmer; Marta Smith; Ben Farmer; Jose M Irimia; Wanda Snead; Margaret Lautz; Peter J Roach; Alan D Cherrington
Journal:  J Clin Invest       Date:  2010-11-15       Impact factor: 14.808

2.  Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog.

Authors:  Justin M Gregory; Noelia Rivera; Guillaume Kraft; Jason J Winnick; Ben Farmer; Eric J Allen; E Patrick Donahue; Marta S Smith; Dale S Edgerton; Phillip E Williams; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-16       Impact factor: 4.310

3.  Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion.

Authors:  J C Pickup; G C Viberti; R W Bilous; H Keen; K G Alberti; P D Home; C Binder
Journal:  Diabetologia       Date:  1982-03       Impact factor: 10.122

4.  Sustained oscillations of insulin, glucagon, and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration.

Authors:  J I Stagner; E Samols; G C Weir
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

5.  Selective potentiation of insulin-mediated glucose disposal in normal dogs by the sulfonylurea glipizide.

Authors:  W S Putnam; D K Andersen; R S Jones; H E Lebovitz
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

6.  Adrenergic influence on glucocounterregulation in man.

Authors:  U Lilavivat; R G Brodows; R G Campbell
Journal:  Diabetologia       Date:  1981-04       Impact factor: 10.122

7.  Assessment of insulin action and glucose effectiveness in diabetic and nondiabetic humans.

Authors:  A A Alzaid; S F Dinneen; D J Turk; A Caumo; C Cobelli; R A Rizza
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

8.  Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects.

Authors:  T F Tse; W E Clutter; S D Shah; J P Miller; P E Cryer
Journal:  J Clin Invest       Date:  1983-07       Impact factor: 14.808

9.  EphA5-EphrinA5 interactions within the ventromedial hypothalamus influence counterregulatory hormone release and local glutamine/glutamate balance during hypoglycemia.

Authors:  Barbara Szepietowska; Wanling Zhu; Jan Czyzyk; Tore Eid; Robert S Sherwin
Journal:  Diabetes       Date:  2012-12-28       Impact factor: 9.461

10.  Sucrose feeding in mouse pregnancy leads to hypertension, and sex-linked obesity and insulin resistance in female offspring.

Authors:  Anne-Maj Samuelsson; Phillippa A Matthews; Eugene Jansen; Paul D Taylor; Lucilla Poston
Journal:  Front Physiol       Date:  2013-02-18       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.